Saxenda® LeafLet

1 ml of solution of Saxenda® contains ____ mg of liraglutide. One pre-filled pen contains ____ mg of liraglutide in ____ ml solution.

Therapeutic Indications of Saxenda® in Adults:

Therapeutic Indications of Saxenda® in Adolescents:

According to the Saxenda® Leaflet :

Treatment in adults with Saxenda® should be discontinued after 12 weeks on the 3.0 mg/day dose if patients have not lost at least ____ of their initial body weight.

• 5%

• 4%

According to the Saxenda® Leaflet :

Treatment in adolescents with Saxenda® should be discontinued and re-evaluated if patients have not lost at least ____ of their BMI or BMI z score after 12 weeks on the 3.0 mg/day or maximum tolerated dose.

• 4%

• 5%

pH of Saxenda® :

• 7.15

• 7.5

• 8.15

• 8.5

If a dose is missed and there is less than 12 hours to the next dose, then?

• The patient should take the dose as soon as possible.

• The patient should not take the missed dose and resume the once-daily regimen with the next scheduled dose.

Saxenda® can be used in combination with another GLP-1 receptor agonist.

• True

• False

No dose adjustment is required for patients with mild or moderate renal impairment, if:

• Creatinine Clearance ≥30 ml/min

• Creatinine Clearance <30 ml/min

If escalation to the next dose step is not tolerated for three consecutive weeks, consider discontinuing treatment.

• True

• False